BAY 1238097

CAS No. 1564268-08-1

BAY 1238097 ( BAY1238097 )

Catalog No. M12230 CAS No. 1564268-08-1

BAY 1238097 is a novel BET bromodomain inhibitor with IC50 of 50 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 710 Get Quote
100MG 1224 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BAY 1238097
  • Note
    Research use only, not for human use.
  • Brief Description
    BAY 1238097 is a novel BET bromodomain inhibitor with IC50 of 50 nM.
  • Description
    BAY 1238097 is a novel BET bromodomain inhibitor with IC50 of 50 nM, inhibits the interaction between BRD4, BRD3 or BRD2 and H4 with IC50 values of 63 nM, 609 nM and 2430 nM in the NanoBRET assay; shows selectivity of the compound for BRD4; strongly reduces c-Myc transcript and protein levels in MOLM-13 (AML) and MOLP-8 (MM) cell lines; exhibits strong efficacy in the AML models THP-1, MOLM-13 and KG-1.
  • Synonyms
    BAY1238097
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1564268-08-1
  • Formula Weight
    451.57
  • Molecular Formula
    C25H33N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 150 mg/mL 332.18 mM
  • SMILES
    O=C(N1N=C(C2=CC=C(N3CCN(C)CC3)C=C2)C4=CC(OC)=C(OC)C=C4C[C@@H]1C)NC
  • Chemical Name
    (S)-7,8-dimethoxy-N,4-dimethyl-1-(4-(4-methylpiperazin-1-yl)phenyl)-4,5-dihydro-3H-benzo[d][1,2]diazepine-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bernasconi E, et al. Br J Haematol. 2017 Jun 27. doi: 10.1111/bjh.14803.
2. Patent WO2014026997A1.
molnova catalog
related products
  • BAY-850

    BAY-850 (BAY 850, BAY850) is a potent, isoform selective, cellularly active ATAD2 bromodomain inhibitor with binding IC50 of 166 nM in TR-FRET assay.

  • biBET

    biBET is a potent, selective, bivalent inhibitor of BET bromodomains.

  • GNE-207

    GNE-207 (GNE207) is a novel potent, selective, orally active CBP/p300 bromodomain with IC50 of 1.0 nM.